» Articles » PMID: 31320461

Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area Under the Curve Values Derived from DCE-MRI

Overview
Specialty Neurology
Date 2019 Jul 20
PMID 31320461
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Early detection of local recurrence is important to increase the chance of cure because local recurrence is the main cause of treatment failure in head and neck squamous cell carcinoma. We evaluated the added value of voxel-based color maps of dynamic contrast-enhanced MR imaging compared with conventional MR imaging alone for detecting local recurrence of head and neck squamous cell carcinoma.

Materials And Methods: We retrospectively enrolled 63 consecutive patients with head and neck squamous cell carcinoma after definitive treatment and posttreatment surveillance MR imaging studies that demonstrated focal enhancement at the primary site. Three independent readers assessed conventional MR imaging and a pair of color maps of initial and final 90-second time-signal intensity areas under the curve from dynamic contrast-enhanced MR imaging. The sensitivities, specificities, and accuracies of both conventional MR imaging alone and combined interpretation of conventional and dynamic contrast-enhanced MR imaging were assessed using the clinicopathologic diagnosis as the criterion standard. κ statistics were used to evaluate interreader agreement.

Results: There were 28 patients with subsequently documented local recurrence and 35 with posttreatment change. Adding dynamic contrast-enhanced MR imaging to conventional MR imaging significantly increased the diagnostic accuracies for detecting local recurrence (48%-54% versus 87%-91%; < .05), with excellent interreader agreement (κ = 0.8; 95% CI, 0.67-0.92 to κ = 0.81; 95% CI, 0.69-0.93). By all 3 readers, the specificities were also significantly improved by adding dynamic contrast-enhanced MR imaging to conventional MR imaging (22%-43% versus 87%-91%; < .001) without sacrificing the sensitivities (68%-82% versus 86%-89%; > .05).

Conclusions: Adding voxel-based color maps of initial and final 90-second time-signal intensity areas under the curve from dynamic contrast-enhanced MR imaging to conventional MR imaging increases the diagnostic accuracy to detect local recurrence in head and neck squamous cell carcinoma by improving the specificity without sacrificing the sensitivity.

Citing Articles

Clinical and Radiological Features of Diffuse Lacrimal Gland Enlargement: Comparisons among Various Etiologies in 91 Biopsy-Confirmed Patients.

Chung S, Kim G, Choi Y, Cho K, Suh C, Kim S Korean J Radiol. 2022; 23(10):976-985.

PMID: 36098340 PMC: 9523236. DOI: 10.3348/kjr.2022.0233.


Dynamic contrast-enhanced MRI can quantitatively identify malignant transformation of sinonasal inverted papilloma.

Li Z, Xian M, Guo J, Wang C, Zhang L, Xian J Br J Radiol. 2022; 95(1134):20211374.

PMID: 35234501 PMC: 10996421. DOI: 10.1259/bjr.20211374.


Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Albano D, Bruno F, Agostini A, Angileri S, Benenati M, Bicchierai G Jpn J Radiol. 2021; 40(4):341-366.

PMID: 34951000 DOI: 10.1007/s11604-021-01223-4.


CT and MRI Findings of Glomangiopericytoma in the Head and Neck: Case Series Study and Systematic Review.

Suh C, Lee J, Lee M, Cho S, Chung S, Choi Y AJNR Am J Neuroradiol. 2019; 41(1):155-159.

PMID: 31806599 PMC: 6975315. DOI: 10.3174/ajnr.A6336.

References
1.
Furukawa M, Parvathaneni U, Maravilla K, Richards T, Anzai Y . Dynamic contrast-enhanced MR perfusion imaging of head and neck tumors at 3 Tesla. Head Neck. 2012; 35(7):923-9. DOI: 10.1002/hed.23051. View

2.
Ailianou A, Mundada P, de Perrot T, Pusztaszieri M, Poletti P, Becker M . MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter. AJNR Am J Neuroradiol. 2018; 39(4):748-755. PMC: 7410767. DOI: 10.3174/ajnr.A5548. View

3.
King A, Keung C, Yu K, Mo F, Bhatia K, Yeung D . T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol. 2013; 34(6):1237-41. PMC: 7964595. DOI: 10.3174/ajnr.A3378. View

4.
Evelhoch J, LoRusso P, He Z, DelProposto Z, Polin L, Corbett T . Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126. Clin Cancer Res. 2004; 10(11):3650-7. DOI: 10.1158/1078-0432.CCR-03-0417. View

5.
Yom S, Machtay M, Biel M, Sinard R, El-Naggar A, Weber R . Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. 2005; 28(4):385-92. DOI: 10.1097/01.coc.0000162422.92095.9e. View